← All companies
RECURSION PHARMACEUTICALS, INC.
RXRX - CIK 0001601830
Market cap$1.61 B
Rank#2257
SEC filings908
The table below shows RECURSION PHARMACEUTICALS, INC.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $743.29M | $594.35M | $391.56M | $549.91M | $285.12M |
| Short-term investments | - | - | - | $0.00 | $231.45M |
| Receivables | - | - | - | $0.00 | $34.00K |
| Inventory | - | - | - | - | - |
| Total current assets | $812.85M | $714.27M | $438.14M | $569.81M | $534.72M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.